Uhm, yeah. These poor guys are just flat broke...
- Bill Weldon - J&J - $28.7M
- Daniel Vasella - Novartis - $27M
- Miles White - Abbott- $25.6M
- Jeffrey Kindler - Pfizer- $24.7M
- Richard Clark - Merck - $24.6M
- Robert Coury - Mylan - $22.9M
- Kevin Sharer - Amgen - $21.1M
- James Mullen - Biogen Idec - $20M
- John Lechleiter - Eli Lilly - $16.5M
- John Martin - Gilead Sciences - $14.2M
No comments:
Post a Comment